The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid management alone when administered in the acute setting to reduce myocardial infarction, ischemic…
- Investigators
- Carl J Pepine, Michael R Massoomi
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All